Juan Wang

Mrs. Juan Wang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YZYue Zhao
Yue Zhao
JWJiacai Wu
Jiacai Wu
XLXiaolan Liu
Xiaolan Liu
XCxu chen
xu chen
JWJuan Wang
Juan Wang
Natural products are valuable medicinal resources in the field of anti-inflammation due to their significant bioactivity and low antibiotic resistance. Research has demonstrated that many natural products exert notable anti-inflammatory effects by modulating the Toll-like receptor 4 (TLR4) and nuclear factor kappa B (NF-κB) signaling pathways. The research on related signal transduction mechanisms and pharmacological mechanisms is increasingly being discovered and validated. However, there is currently a lack of comprehensive reviews focusing on the pharmacological mechanisms of natural products targeting the TLR4/NF-κB pathway for anti-inflammatory effects. In light of these considerations, this review comprehensively synthesizes recent research findings concerning the TLR4/NF-κB signaling pathway, including the translocation of TLR4 activation to lysosomes within the cytoplasm, the assembly of protein complexes mediated by ubiquitin chains K63 and K48, and the deacetylation modification of p65. These discoveries are integrated into the classical TLR4/NF-κB pathway to systematically elucidate the latest mechanisms among various targets. Additionally, we summarize the pharmacological mechanisms by which natural products exert anti-inflammatory effects through the TLR4/NF-κB pathway. This aims to elucidate the multitarget advantages of natural products in the treatment of inflammation and their potential applications, thereby providing theoretical support for molecular pharmacology research on inflammation and the development of novel natural anti-inflammatory drugs.

1 October 2021 in Biochemical Pharmacology
Verified
Journal Article
Closed access
XGXiao Guan
Xiao Guan
DYDan Yu
Dan Yu
MHMengjie HuangFu
Mengjie HuangFu
ZHZhiyi Huang
Zhiyi Huang
TDTong Dou
Tong Dou
XCxu chen
xu chen

17 February 2021 in Oncology Letters
Verified
Journal Article
Open access
PDF file
DYDan Yu
Dan Yu
HLHaiping Liu
Haiping Liu
JQJianli Qin
Jianli Qin
MHMengjie Huangfu
Mengjie Huangfu
XGXiao Guan
Xiao Guan
XCxu chen
xu chen
MicroRNA‑30a‑5p (miR‑30a‑5p), which functions as a tumor suppressor, has been reported to be downregulated in colorectal cancer (CRC) tissues and to be associated with cancer invasion. However, the detailed regulatory mechanism of curcumol in the malignant progression of CRC remains unknown. MTT, Transwell, scratch, western blotting and reverse transcription‑quantitative PCR assays were performed to examine how curcumol inhibited CRC cell viability, invasion and migration, and to detect the role of miR‑30a‑5p and curcumol in the invasion and Hippo signaling pathways of CRC cells. The present study revealed that miR‑30a‑5p expression was downregulated in human CRC tissues and cells. The results demonstrated that miR‑30a‑5p downregulation was accompanied by the inactivation of the Hippo signaling pathway, which was demonstrated to promote CRC cell viability, invasion and migration. Curcumol treatment was identified to increase miR‑30a‑5p expression and to activate the Hippo signaling pathway, which in turn inhibited the invasion and migration of CRC cells. Overexpression of miR‑30a‑5p enhanced the effects of curcumol on cell invasion and migration, and the Hippo signaling pathway in CRC cells. Furthermore, downregulation of miR‑30a‑5p reversed the effects of curcumol on cell invasion and migration, and the Hippo signaling pathway in CRC cells. These findings identified novel signaling pathways associated with miR‑30a‑5p and revealed the effects of curcumol on miR‑30a‑5p expression. Therefore, curcumol may serve as a potential therapeutic strategy to delay CRC progression.

8 November 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
JWJuan Wang
Juan Wang
GLGuoxiang Liu
Guoxiang Liu
XLXiaojuan Li
Xiaojuan Li
MHMengjie Huangfu
Mengjie Huangfu
YLYisa Liu
Yisa Liu
XCxu chen
xu chen

11 January 2024 in Food & Function
Verified
Journal Article
Closed access
PDF file
MHMengjie Han
Mengjie Han
HLHaiping Liu
Haiping Liu
GLGuoxiang Liu
Guoxiang Liu
XLXiaojuan Li
Xiaojuan Li
LZLuwei Zhou
Luwei Zhou
XCxu chen
xu chen
Mogroside V (MV) is a natural sweetener extracted from the edible plant Siraitia grosvenorii that possesses anti-inflammatory bioactivity.

26 April 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RARui Ai
Rui Ai
MTMuzhao Tian
Muzhao Tian
JSJiawang Sun
Jiawang Sun
SHShuying He
Shuying He
ZCZhi Cui
Zhi Cui
JWJuan Wang
Juan Wang